Biological and physicochemical characterization of a serumand xeno-free chemically defined cryopreservation procedure for adult human progenitor cells

Cell Transplantation

Volumn 20, Issue 8, 2011, Pages 1241-1257

  Zeisberger, Steffen M ^a,b   Schulz, Julia C ^c   Mairhofer, Mario ^d   Ponsaerts, Peter ^e   Wouters, Guy ^f   Doerr, Daniel ^c   Katsen Globa, Alisa ^c   Ehrbar, Martin ^a   Hescheler, Jurgen ^g   Hoerstrup, Simon P ^b   Zisch, Andreas H ^a   Kolbus, Andrea ^d   Zimmermann, Heiko ^c,h  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c FRAUNHOFER INSTITUTE FOR BIOMEDICAL ENGINEERING   (Germany)

^d UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f Cryo Save Group   (Belgium)

^g UNIVERSITY OF COLOGNE   (Germany)

^h SAARLAND UNIVERSITY   (Germany)

Author keywords

Chemically defined; Cryomicroscopy; Cryopreservation; Current good manufacturing practice; Human progenitor and mesenchymal stem cells; Serum free; Xeno free

Indexed keywords

BOVINE SERUM ALBUMIN; DIMETHYL SULFOXIDE;

ADULT; ARTICLE; CELL POPULATION; CELL STRUCTURE; CELL VIABILITY; COLONY FORMING CELL; CONTROLLED STUDY; CRYOPRESERVATION; CRYOPROTECTION; ERYTHROID CELL; FREEZE THAWING; HUMAN; HUMAN CELL; LASER SCANNING CYTOMETRY; OSMOLARITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STEM CELL; STROMA CELL; TISSUE ENGINEERING; UMBILICAL CORD BLOOD;

BOVINAE;

EID: 84930485300     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X547426     Document Type: Article

References (57)

1. Alencar, S.; Garnica, M.; Luiz, R. R.; Nogueira, C. M.; Borojevic, R.; Maiolino, A.; Dutra, H. S. Cryopreserva- tion of peripheral blood stem cell: The influence of cell concentration on cellular and hematopoietic recovery. Transfusion 50(11):2402-2412; 2010.
2. Armitage, W. J.; Mazur, P. Osmotic tolerance of human granulocytes. Am. J. Physiol. 247(5 Pt. 1):C373-381; 1984.
3. Asher, D. M. The transmissible spongiform encephalopathy agents: Concerns and responses of United States regulatory agencies in maintaining the safety of biologics. Dev. Biol. Stand. 100:103-118; 1999.
4. Bielanski, A.; Bergeron, H.; Lau, P. C.; Devenish, J. Microbial contamination of embryos and semen during long term banking in liquid nitrogen. Cryobiology 46(2):146-152; 2003.
5. Bosshard, P. P.; Kronenberg, A.; Zbinden, R.; Ruef, C.; Bottger, E. C.; Altwegg, M. Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: A 3-year experience. Clin. Infect. Dis. 37(2):167-172; 2003.
6. Bradley, R. Bovine spongiform encephalopathy and its relationship to the variant form of Creutzfeldt-Jakob disease. Contrib. Microbiol. 11:146-185; 2004.
7. Brooke, G.; Rossetti, T.; Pelekanos, R.; Ilic, N.; Murray, P.; Hancock, S.; Antonenas, V.; Huang, G.; Gottlieb, D.; Bradstock, K.; Atkinson, K. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. Br. J. Haematol. 144(4):571-579; 2009.
8. Dankberg, F.; Persidsky, M. D. A test of granulocyte membrane integrity and phagocytic function. Cryobiology 13(4):430-432; 1976.
9. Doerr, D.; Stark, M.; Ehrhart, F.; Zimmermann, H.; Stracke, F. Multiphoton microscopy for the in-situ investigation of cellular processes and integrity in cryopreserva- tion. Biotechnol. J. 4(8):1215-1220; 2009.
10. Dolznig, H.; Kolbus, A.; Leberbauer, C.; Schmidt, U.; Deiner, E. M.; Mullner, E. W.; Beug, H. Expansion and differentiation of immature mouse and human hematopoietic progenitors. Methods Mol. Med. 105:323-344; 2005.
11. Fahy, G. M.; Wowk, B.; Wu, J. Cryopreservation of complex systems: The missing link in the regenerative medicine supply chain. Rejuvenation Res. 9(2):279-291; 2006.
12. Gimble, J. M.; Katz, A. J.; Bunnell, B. A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 100(9):1249-1260; 2007.
13. Gomez-Lechon, M. J.; Lahoz, A.; Jimenez, N.; Bonora, A.; Castell, J. V.; Donato, M. T. Evaluation of drug-metabolizing and functional competence of human hepato- cytes incubated under hypothermia in different media for clinical infusion. Cell Transplant. 17(8):887-897; 2008.
14. Gonzalez Hernandez, Y.; Fischer, R. W. Serum-free culturing of mammalian cells-adaptation to and cryopreser- vation in fully defined media. ALTEX 24(2):110-116; 2007.
15. Grein, T. A.; Freimark, D.; Weber, C.; Hudel, K.; Wall-rapp, C.; Czermak, P. Alternatives to dimethylsulfoxide for serum-free cryopreservation of human mesenchymal stem cells. Int. J. Artif. Organs 33(6):370-380; 2010.
16. Gruen, L.; Grabel, L. Concise review: Scientific and ethical roadblocks to human embryonic stem cell therapy. Stem Cells 24(10):2162-2169; 2006.
17. Holm, F.; Strom, S.; Inzunza, J.; Baker, D.; Stromberg, A. M.; Rozell, B.; Feki, A.; Bergstrom, R.; Hovatta, O. An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripo- tent stem cells. Hum. Reprod. 25(5):1271-1279; 2010.
18. Hubalek, Z. Protectants used in the cryopreservation of microorganisms. Cryobiology 46(3):205-229; 2003.
19. Hubbard, W. K. Quality of biotechnological/biological products: Derivation and characterization of cell substrates used for production of biotechnological/biological products. Fed. Regist. 63:50244-50249; 1998.
20. Ishikawa, T.; Banas, A.; Hagiwara, K.; Iwaguro, H.; Ochiya, T. Stem cells for hepatic regeneration: The role of adipose tissue derived mesenchymal stem cells. Curr. Stem Cell Res. Ther. 5(2):182-189; 2010.
21. Janetzki, S.; Panageas, K. S.; Ben-Porat, L.; Boyer, J.; Britten, C. M.; Clay, T. M.; Kalos, M.; Maecker, H. T.; Romero, P.; Yuan, J.; Kast, W. M.; Hoos, A. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol. Im- munother. 57(3):303-315; 2008.
22. Junior, A. M.; Arrais, C. A.; Saboya, R.; Velasques, R. D.; Junqueira, P. L.; Dulley, F. L. Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion. Bone Marrow Transplant. 41(1):95-96; 2008.
23. Katsen, A. D.; Rikberg, A. B. A method of phase-contrast, fluorescence and scanning electron microscopy of one and the same cultured cells undergoing cryogenic action. Tsi- tologiia 33(5):76-81; 1991.
24. Koc, O. N.; Day, J.; Nieder, M.; Gerson, S. L.; Lazarus, H. M.; Krivit, W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 30(4):215-222; 2002.
25. Korhonen, M. Culture of human mesenchymal stem cells in serum-free conditions: No breakthroughs yet. Eur. J. Haematol. 78(2):167; 2007.
26. Leberbauer, C.; Boulme, F.; Unfried, G.; Huber, J.; Beug, H.; Mullner, E. W. Different steroids co-regulate longterm expansion versus terminal differentiation in primary human erythroid progenitors. Blood 105(1):85-94; 2005.
27. Le Blanc, K.; Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M. E.; Remberger, M.; Dini, G.; Egeler, R. M.; Bacigalupo, A.; Fibbe, W.; Ringden, O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371(9624):1579-1586; 2008.
28. Lee, I. C.; Wang, J. H.; Lee, Y. T.; Young, T. H. The differentiation of mesenchymal stem cells by mechanical stress or/and co-culture system. Biochem. Biophys. Res. Commun. 352(1):147-152; 2007.
29. Liu, Y.; Xu, X.; Ma, X.; Martin-Rendon, E.; Watt, S.; Cui, Z. Cryopreservation of human bone marrow-derived mesenchymal stem cells with reduced dimethylsulfoxide and well-defined freezing solutions. Biotechnol. Prog. 26(6): 1635-1643; 2010.
30. Lu, X.; Proctor, S. J.; Dickinson, A. M. The effect of cryo- preservation on umbilical cord blood endothelial progenitor cell differentiation. Cell Transplant. 17(12):1423-1428; 2008.
31. Luciano, A. M.; Chigioni, S.; Lodde, V.; Franciosi, F.; Luvoni, G. C.; Modina, S. C. Effect of different cryopres- ervation protocols on cytoskeleton and gap junction mediated communication integrity in feline germinal vesicle stage oocytes. Cryobiology 59(1):90-95; 2009.
32. Mackensen, A.; Drager, R.; Schlesier, M.; Mertelsmann, R.; Lindemann, A. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol. Immunother. 49(3):152-156; 2000.
33. Martin, M. J.; Muotri, A.; Gage, F.; Varki, A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11(2):228-232; 2005.
34. Mason, C.; Manzotti, E. Regenerative medicine cell therapies: Numbers of units manufactured and patients treated between 1988 and 2010. Regen. Med. 5(3):307-313; 2010.
35. Matsumura, K.; Bae, J. Y.; Hyon, S. H. Polyampholytes as cryoprotective agents for mammalian cell cryopreserva- tion. Cell Transplant. 19(6/7):691-699; 2010.
36. Meryman, H. T. Freezing injury and its prevention in living cells. Annu. Rev. Biophys. Bioeng. 3:341-363; 1974.
37. Miyamoto, Y.; Enosawa, S.; Takeuchi, T.; Takezawa, T. Cryopreservation in situ of cell monolayers on collagen vitrigel membrane culture substrata: Ready-to-use preparation of primary hepatocytes and ES cells. Cell Transplant. 18(5/6):619-626; 2009.
38. Parolini, O.; Alviano, F.; Bergwerf, I.; Boraschi, D.; De Bari, C.; De Waele, P.; Dominici, M.; Evangelista, M.; Falk, W.; Hennerbichler, S.; Hess, D. C.; Lanzoni, G.; Liu, B.; Marongiu, F.; McGuckin, C.; Mohr, S.; Nolli, M. L.; Ofir, R.; Ponsaerts, P.; Romagnoli, L.; Solomon, A.; Soncini, M.; Strom, S.; Surbek, D.; Venkatachalam, S.; Wolbank, S.; Zeisberger, S.; Zeitlin, A.; Zisch, A.; Borlongan, C. V. Toward cell therapy using placenta- derived cells: Disease mechanisms, cell biology, preclini- cal studies, and regulatory aspects at the round table. Stem Cells Dev. 19(2):143-154; 2010.
39. Reinisch, A. I. Characteristics of six recent animal hoarding cases in Manitoba. Can. Vet. J. 50(10):1069-1073; 2009.
40. Reubinoff, B. E.; Pera, M. F.; Vajta, G.; Trounson, A. O. Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum. Re- prod. 16(10):2187-2194; 2001.
41. Rodrigues, J. P.; Paraguassu-Braga, F. H.; Carvalho, L.; Abdelhay, E.; Bouzas, L. F.; Porto, L. C. Evaluation of trehalose and sucrose as cryoprotectants for hematopoietic stem cells of umbilical cord blood. Cryobiology 56(2): 144-151; 2008.
42. Schafer, R.; Dominici, M.; Muller, I.; Dazzi, F.; Bieback, K.; Godthardt, K.; Le Blanc, K.; Meisel, R.; Pochampally, R.; Richter, R.; Skutella, T.; Steinhoff, G.; Mitterberger, M.; Wendel, H.; Wiskirchen, J.; Handgretinger, R.; North-off, H. Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tubingen, Germany. Cytotherapy 9(4): 397-405; 2007.
43. Schmidt, D.; Asmis, L. M.; Odermatt, B.; Kelm, J.; Brey- mann, C.; Gossi, M.; Genoni, M.; Zund, G.; Hoerstrup, S. P. Engineered living blood vessels: Functional endothe- lia generated from human umbilical cord-derived progenitors. Ann. Thorac. Surg. 82(4):1465-1471; 2006.
44. Selvaggi, T. A.; Walker, R. E.; Fleisher, T. A. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89(3): 776-779; 1997.
45. Shantsila, E.; Watson, T.; Lip, G. Y. Endothelial progenitor cells in cardiovascular disorders. J. Am. Coll. Cardiol. 49(7):741-752; 2007.
46. Tapp, H.; Hanley, Jr., E. N.; Patt, J. C.; Gruber, H. E. Adipose-derived stem cells: Characterization and current application in orthopaedic tissue repair. Exp. Biol. Med. (Maywood) 234(1):1-9; 2009.
47. Thirumala, S.; Goebel, W. S.; Woods, E. J. Clinical grade adult stem cell banking. Organogenesis 5(3):143-154; 2009.
48. Timmermans, F.; Plum, J.; Yoder, M. C.; Ingram, D. A.; Vandekerckhove, B.; Case, J. Endothelial progenitor cells: Identity defined? J. Cell. Mol. Med. 13(1):87-102; 2009.
49. Tuschong, L.; Soenen, S. L.; Blaese, R. M.; Candotti, F.; Muul, L. M. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum. Gene Ther. 13(13):1605-1610; 2002.
50. Vrhovac, R.; Peric, Z.; Jurenec, S.; Kardum-Skelin, I.; Jelic-Puskaric, B.; Jaksic, B. Post-thaw viability of cryo- preserved hematopoietic progenitor cell grafts: Does it matter? Coll. Antropol. 34(1):163-169; 2010.
51. Wagner, K.; Welch, D. Cryopreserving and recovering of human iPS cells using complete knockout serum replacement feeder-free medium. J. Vis. Exp. 41; 2010.
52. Will, R. G.; Ironside, J. W.; Zeidler, M.; Cousens, S. N.; Estibeiro, K.; Alperovitch, A.; Poser, S.; Pocchiari, M.; Hofman, A.; Smith, P. G. A new variant of Creutzfeldt- Jakob disease in the UK. Lancet 347(9006):921-925; 1996.
53. Windrum, P.; Morris, T. C. Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplant. 31(4):315; 2003.
54. Yoder, M. C.; Ingram, D. A. The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: Is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? Biochim. Biophys. Acta 1796(1):50-54; 2009.
55. Zavan, B.; Vindigni, V.; Gardin, C.; D'Avella, D.; Della Puppa, A.; Abatangelo, G.; Cortivo, R. Neural potential of adipose stem cells. Discov. Med. 10(50):37-43; 2010.
56. Zeisberger, S. M.; Zoller, S.; Riegel, M.; Chen, S.; Kren- ning, G.; Harmsen, M. C.; Sachinidis, A.; Zisch, A. H. Optimization of the culturing conditions of human umbilical cord blood-derived endothelial colony-forming cells under xeno-free conditions applying a transcriptomic approach. Genes Cells 15(7):671-687; 2010.
57. Zuk, P. A.; Zhu, M.; Ashjian, P.; De Ugarte, D. A.; Huang, J. I.; Mizuno, H.; Alfonso, Z. C.; Fraser, J. K.; Benhaim, P.; Hedrick, M. H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13(12): 4279-4295; 2002.